Miyazaki Y, Kiguchi T, Sato S, Usuki K, et al. Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial. Int J Hematol 2022;116:228-238.
PMID: 35508695